The South and Central America dermal fillers market is expected to reach US$ 600.67 million by 2028 from US$ 295.63 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028.
The growth of the market is attributed to the factors such as preference for minimally invasive procedures, growth in population of age 30–65 years, and rise in the attraction of consumers toward beauty and wellness. However, the high cost of surgeries hinders the South and Central America Dermal Fillers market growth.
In recent years, the adoption of minimally invasive procedures has increased worldwide. Several minimally invasive dermatological techniques have been developed for facial rejuvenation. Injectable dermal fillers can be injected through a needle into the upper layers of the dermis to treat superficial fine wrinkles or into the deep dermis or subcutaneous space for facial volume augmentation. According to the statistics from the American Society of Plastic Surgeons (ASPS), more than 2.7 million dermal filler procedures were performed in 2019. Further, Allergan stated that the unit sales of dermal filler treatments increased by 17%. Age is a significant factor governing specific needs regarding medical aesthetic procedures. People of age 35–55 prefer minimally invasive aesthetic procedures over surgery. Minimally invasive cosmetic and aesthetic procedures have now become an established interdisciplinary topic, and plastic surgeons showing greater will to explore them. The rise of nonsurgical technologies and new treatment options has made aesthetics more accessible to a broader audience. Collectively, the greater benefits and accuracy of minimally invasive procedures over traditional surgical procedures are expected to drive the market during the forecast period. The ever-increasing interest in retaining a youthful physical appearance has facilitated various minimally invasive dermatological techniques. With the ever-increasing popularity of nonsurgical enhancement and a growing number of patients who have been treated, the demand for fillers continues to rise. Also, the surging inclination among people of age of 30–65 with signs of aging, such as lack of skin elasticity, wrinkles, and dark spots, is anticipated to drive the demand for dermal fillers in the coming years.
Latin American countries are witnessing continuous rise in COVID-19 cases. Currently, countries in this region are rapidly increasing clinical programs to fight the disease, and the healthcare sectors have redirected their focus toward its management. Many dermatology clinics were shut down in 2020. Thus, the dermal fillers market in South and Central America has witnessed negative effect of the COVID-19 pandemic.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
SOUTH AND CENTRAL AMERICA DERMAL FILLERS MARKET SEGMENTATION
By Product
- Biodegradable
- Non-Biodegradable
By Material
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Collagen
- Poly-L-Lactic Acid
- Polymethylmethacrylate (PMMA)
- Fat Fillers
- Other
By Application
- Facial Line Correction Treatment
- Lip Enhancement
- Face Lift
- Scar Treatment
- Others
By End User
- Dermatology Clinics
- Multispecialty Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- AbbVie Inc.
- Galderma
- Merz Pharma
- Suneva Medical
- HUADONG MEDICINE CO., LTD
- Prollenium Medical Technologies
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Dermal Fillers Market – By Product
1.3.2 South and Central America Dermal Fillers Market – By Material
1.3.3 South and Central America Dermal Fillers Market – By Application
1.3.4 South and Central America Dermal Fillers Market – By End User
1.3.5 South and Central America Dermal Fillers Market – By Country
2. Dermal Fillers Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Dermal Fillers Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Dermal Fillers Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Preference for Minimally Invasive Procedures
5.1.2 Growth in Population of 30–65 Age Group
5.1.3 Rising Attraction of Consumers Towards Beauty and Wellness
5.2 Market Restraints
5.2.1 High Cost of Surgeries
5.3 Market Opportunities
5.3.1 Increasing Disposable Incomes and Expanding Middle-Class Population
5.4 Future Trends
5.4.1 Strategic Activities by Market Players
5.4.2 Rise in Adoption of Injectables Fillers Among Male Population
5.5 Impact Analysis
6. Dermal Fillers Market –South and Central America Analysis
6.1 South and Central America Dermal Fillers Market Revenue Forecast and Analysis
7. Dermal Fillers Market Analysis – By Product
7.1 Overview
7.2 Dermal Fillers Market Revenue Share, by Product (2021 and 2028)
7.3 Biodegradable
7.3.1 Overview
7.3.2 Biodegradable: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Non-Biodegradable
7.4.1 Overview
7.4.2 Non-Biodegradable: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
8. Dermal Fillers Market Analysis – By Material
8.1 Overview
8.2 Dermal Fillers Market Revenue Share, by Material (2021 and 2028)
8.3 Calcium Hydroxylapatite
8.3.1 Overview
8.3.2 Calcium Hydroxylapatite: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hyaluronic Acid
8.4.1 Overview
8.4.2 Hyaluronic Acid: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Collagen
8.5.1 Overview
8.5.2 Collagen: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Poly-L-Lactic Acid
8.6.1 Overview
8.6.2 Poly-L-Lactic acid: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Polymethylmethacrylate (PMMA)
8.7.1 Overview
8.7.2 Polymethylmethacrylate (PMMA): Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Fat Fillers
8.8.1 Overview
8.8.2 Fat Fillers: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Other Materials
8.9.1 Overview
8.9.2 Other Materials: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
9. Dermal Fillers Market– By Application
9.1 Overview
9.2 Dermal Fillers Market Share, by Application, 2021 and 2028 (%)
9.3 Facial Line Correction Treatment
9.3.1 Overview
9.3.2 Facial Line Correction Treatment: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
9.4 Lip Enhancement
9.4.1 Overview
9.4.2 Lip Enhancement: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
9.5 Face Lift
9.5.1 Overview
9.5.2 Face Lift: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
9.6 Scar Treatment
9.6.1 Overview
9.6.2 Scar Treatment: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
10. Dermal Fillers Market– By End User
10.1 Overview
10.2 Dermal Fillers Market Share, by End User, 2021 and 2028 (%)
10.3 Multispecialty Hospitals
10.3.1 Overview
10.3.2 Multispecialty hospitals: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
10.4 Dermatology Clinics
10.4.1 Overview
10.4.2 Dermatology Clinics: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
10.5 Ambulatory Surgical Centers
10.5.1 Overview
10.5.2 Ambulatory Surgical Centres: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
10.6 Other End Users
10.6.1 Overview
10.6.2 Other End Users: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
11. Dermal Fillers Market – South and Central America Analysis
11.1 South and Central America: Dermal Fillers Market
11.1.1 Overview
11.1.2 South and Central America: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
11.1.3 South and Central America: Dermal Fillers Market, by Product, 2019–2028 (USD Million)
11.1.4 South and Central America Dermal Fillers Market, by Material – Revenue and Forecast to 2028 (USD Million)
11.1.5 South and Central America: Dermal Fillers Market, by Application, 2019–2028 (USD Million)
11.1.6 South and Central America: Dermal Fillers Market, by End User, 2019–2028 (USD Million)
11.1.7 South and Central America: Dermal Fillers Market, by Country, 2021 & 2028 (%)
11.1.7.1 Brazil: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 Brazil: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 Brazil: Dermal Fillers Market, by Product, 2019–2028 (USD Million)
11.1.7.1.3 Brazil: Dermal Fillers Market, by Material, 2019–2028 (USD Million)
11.1.7.1.4 Brazil: Dermal Fillers Market, by Application, 2019–2028 (USD Million)
11.1.7.1.5 Brazil: Dermal Fillers Market, by End User, 2019–2028 (USD Million)
11.1.7.2 Argentina: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Argentina: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Argentina: Dermal Fillers Market, by Product, 2019–2028 (USD Million)
11.1.7.2.3 Argentina: Dermal Fillers Market, by Material, 2019–2028 (USD Million)
11.1.7.2.4 Argentina: Dermal Fillers Market, by Application, 2019–2028 (USD Million)
11.1.7.2.5 Argentina: Dermal Fillers Market, by End User, 2019–2028 (USD Million)
11.1.7.3 Rest of South and Central America: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Rest of South and Central America: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Rest of South and Central America: Dermal Fillers Market, by Product, 2019–2028 (USD Million)
11.1.7.3.3 Rest of South and Central America: Dermal Fillers Market, by Material, 2019–2028 (USD Million)
11.1.7.3.4 Rest of South and Central America: Dermal Fillers Market, by Application, 2019–2028 (USD Million)
11.1.7.3.5 Rest of South and Central America: Dermal Fillers Market, by End User, 2019–2028 (USD Million)
12. Impact of COVID-19 Pandemic on South and Central America Dermal Fillers Market
12.1 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Dermal Fillers Market– Industry Landscape
13.1 Overview
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 AbbVie Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Galderma
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Merz Pharma
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Suneva Medical
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 HUADONG MEDICINE CO., LTD
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Prollenium Medical Technologies
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America: Dermal Fillers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. South and Central America: Dermal Fillers Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 3. South and Central America: Dermal Fillers Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. South and Central America: Dermal Fillers Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil: Dermal Fillers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil: Dermal Fillers Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil: Dermal Fillers Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Brazil: Dermal Fillers Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina: Dermal Fillers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina: Dermal Fillers Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 11. Argentina: Dermal Fillers Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Argentina: Dermal Fillers Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of South and Central America: Dermal Fillers Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of South and Central America: Dermal Fillers Market, by Material – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of South and Central America: Dermal Fillers Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of South and Central America: Dermal Fillers Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Dermal Fillers Market
LIST OF FIGURES
Figure 1. Dermal Fillers Market Segmentation
Figure 2. Dermal Fillers Market, By Country
Figure 3. Dermal Fillers Market Overview
Figure 4. The Biodegradable Segment Held Largest Share of Product Segment in the Dermal Fillers Market
Figure 5. South and Central America Dermal Fillers Market- Leading Country Markets (USD Million)
Figure 6. South and Central America (SCAM) PEST Analysis
Figure 7. Dermal Fillers Market Impact Analysis of Drivers and Restraint
Figure 8. South and Central America Dermal Fillers Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Dermal Fillers Market Revenue Share, by Product (2021 and 2028)
Figure 10. Biodegradable: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Non-Biodegradable: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Dermal Fillers Market Revenue Share, by Material (2021 and 2028)
Figure 13. Calcium Hydroxylapatite: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Hyaluronic Acid: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Collagen: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Poly-L-Lactic acid: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Polymethylmethacrylate (PMMA): Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Fat Fillers: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Materials: Dermal Fillers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dermal Fillers Market Share, by Application, 2021 and 2028 (%)
Figure 21. Facial Line Correction Treatment: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 22. Lip Enhancement: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 23. Face Lift: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 24. Scar Treatment: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 25. Others: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 26. Dermal Fillers Market Share, by End User, 2021 and 2028 (%)
Figure 27. Multispecialty Hospitals: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 28. Dermatology Clinics: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 29. Ambulatory Surgical Centers: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 30. Other End Users: Dermal Fillers Market– Revenue and Forecast to 2028 (USD Million)
Figure 31. South and Central America: Dermal Fillers Market, by Key Country – Revenue (2021) (USD Million)
Figure 32. South and Central America Dermal Fillers Market Revenue and Forecast to 2028 (USD Million)
Figure 33. South and Central America: Dermal Fillers Market, by Country, 2021 & 2028 (%)
Figure 34. Brazil: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Argentina: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of South and Central America: Dermal Fillers Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in South and Central America Market
- AbbVie Inc.
- Galderma
- Merz Pharma
- Suneva Medical
- HUADONG MEDICINE CO., LTD
- Prollenium Medical Technologies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to South and Central America Dermal Fillers Market
Oct 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Oct 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Oct 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)